213 related articles for article (PubMed ID: 31171583)
1. Drug repurposing in neurological diseases: an integrated approach to reduce trial and error.
Clout AE; Della Pasqua O; Hanna MG; Orlu M; Pitceathly RDS
J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1270-1275. PubMed ID: 31171583
[TBL] [Abstract][Full Text] [Related]
2. Repurposing old molecules for new indications: Defining pillars of success from lessons in the past.
Mittal N; Mittal R
Eur J Pharmacol; 2021 Dec; 912():174569. PubMed ID: 34653378
[TBL] [Abstract][Full Text] [Related]
3. Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases.
Rani N; Kaushik A; Kardam S; Kag S; Raj VS; Ambasta RK; Kumar P
Prog Mol Biol Transl Sci; 2024; 205():23-70. PubMed ID: 38789181
[TBL] [Abstract][Full Text] [Related]
4. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing in rare diseases: Myths and reality.
Fetro C; Scherman D
Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
[TBL] [Abstract][Full Text] [Related]
6. Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.
Chen H; Wu J; Gao Y; Chen H; Zhou J
Curr Top Med Chem; 2016; 16(19):2107-14. PubMed ID: 26881709
[TBL] [Abstract][Full Text] [Related]
7. Revisiting Repurposing.
Sharlow ER
Assay Drug Dev Technol; 2016 Dec; 14(10):554-556. PubMed ID: 27982703
[TBL] [Abstract][Full Text] [Related]
8. Accelerating space radiation countermeasure development through drug repurposing.
Madrid PB; Chang PY
Life Sci Space Res (Amst); 2022 Nov; 35():30-35. PubMed ID: 36336366
[TBL] [Abstract][Full Text] [Related]
9. Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments.
Juárez-López D; Schcolnik-Cabrera A
Arch Med Res; 2021 Apr; 52(3):243-251. PubMed ID: 33190955
[TBL] [Abstract][Full Text] [Related]
10. Drug repurposing from the perspective of pharmaceutical companies.
Cha Y; Erez T; Reynolds IJ; Kumar D; Ross J; Koytiger G; Kusko R; Zeskind B; Risso S; Kagan E; Papapetropoulos S; Grossman I; Laifenfeld D
Br J Pharmacol; 2018 Jan; 175(2):168-180. PubMed ID: 28369768
[TBL] [Abstract][Full Text] [Related]
11. Using human experience to identify drug repurposing opportunities: theory and practice.
Cavalla D
Br J Clin Pharmacol; 2019 Apr; 85(4):680-689. PubMed ID: 30648285
[TBL] [Abstract][Full Text] [Related]
12. Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.
Lago SG; Bahn S
ACS Chem Neurosci; 2019 Jan; 10(1):58-78. PubMed ID: 29944339
[TBL] [Abstract][Full Text] [Related]
13. Repurposed agents in the Alzheimer's disease drug development pipeline.
Bauzon J; Lee G; Cummings J
Alzheimers Res Ther; 2020 Aug; 12(1):98. PubMed ID: 32807237
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and Systems Pharmacology Approaches to Repurposing Drugs in the Wake of Global Health Burden.
Bai JPF
J Pharm Sci; 2016 Oct; 105(10):3007-3012. PubMed ID: 27522921
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing in cardiovascular diseases: Opportunity or hopeless dream?
Gelosa P; Castiglioni L; Camera M; Sironi L
Biochem Pharmacol; 2020 Jul; 177():113894. PubMed ID: 32142728
[TBL] [Abstract][Full Text] [Related]
16. Old wine in new bottles: Drug repurposing in oncology.
Antoszczak M; Markowska A; Markowska J; Huczyński A
Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
[TBL] [Abstract][Full Text] [Related]
17. Approaches of pre-clinical and clinical trials of repurposed drug.
Israr J; Alam S; Kumar A
Prog Mol Biol Transl Sci; 2024; 205():259-275. PubMed ID: 38789183
[TBL] [Abstract][Full Text] [Related]
18. Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.
Johnston TH; Lacoste AMB; Visanji NP; Lang AE; Fox SH; Brotchie JM
Neuropharmacology; 2019 Mar; 147():11-27. PubMed ID: 29907424
[TBL] [Abstract][Full Text] [Related]
19. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing: a promising tool to accelerate the drug discovery process.
Parvathaneni V; Kulkarni NS; Muth A; Gupta V
Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
